Hefei Lifeon Pharmaceutical Co., Ltd. 003020.SZ Stock
Hefei Lifeon Pharmaceutical Co., Ltd. Price Chart
Hefei Lifeon Pharmaceutical Co., Ltd. 003020.SZ Financial and Trading Overview
Hefei Lifeon Pharmaceutical Co., Ltd. stock price | 20.19 CNY |
Previous Close | 40.27 CNY |
Open | 40.28 CNY |
Bid | 40.56 CNY x N/A |
Ask | 40.6 CNY x N/A |
Day's Range | 39.8 - 40.67 CNY |
52 Week Range | 19.54 - 44.66 CNY |
Volume | 467.36K CNY |
Avg. Volume | 1.77M CNY |
Market Cap | 6.46B CNY |
Beta (5Y Monthly) | 0.16192 |
PE Ratio (TTM) | 28.55634 |
EPS (TTM) | 1.33 CNY |
Forward Dividend & Yield | 0.5 (1.20%) |
Ex-Dividend Date | May 24, 2023 |
1y Target Est | N/A |
003020.SZ Valuation Measures
Enterprise Value | 5.85B CNY |
Trailing P/E | 28.55634 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.3369234 |
Price/Book (mrq) | 4.157695 |
Enterprise Value/Revenue | 2.117 |
Enterprise Value/EBITDA | 24.197 |
Trading Information
Hefei Lifeon Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.16192 |
52-Week Change | 81.96% |
S&P500 52-Week Change | 20.43% |
52 Week High | 44.66 CNY |
52 Week Low | 19.54 CNY |
50-Day Moving Average | 38.38 CNY |
200-Day Moving Average | 31.08 CNY |
003020.SZ Share Statistics
Avg. Volume (3 month) | 1.77M CNY |
Avg. Daily Volume (10-Days) | 1.29M CNY |
Shares Outstanding | 159.21M |
Float | 62.69M |
Short Ratio | N/A |
% Held by Insiders | 65.60% |
% Held by Institutions | 6.40% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.385 |
Trailing Annual Dividend Yield | 0.95% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.3684 |
Last Split Factor | 1.3:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 8.27% |
Operating Margin (ttm) | 7.87% |
Gross Margin | 36.59% |
EBITDA Margin | 8.75% |
Management Effectiveness
Return on Assets (ttm) | 6.46% |
Return on Equity (ttm) | 15.74% |
Income Statement
Revenue (ttm) | 2.76B CNY |
Revenue Per Share (ttm) | 17.7 CNY |
Quarterly Revenue Growth (yoy) | 29.09% |
Gross Profit (ttm) | N/A |
EBITDA | 241.72M CNY |
Net Income Avi to Common (ttm) | 228.62M CNY |
Diluted EPS (ttm) | 1.42 |
Quarterly Earnings Growth (yoy) | 40.30% |
Balance Sheet
Total Cash (mrq) | 606.36M CNY |
Total Cash Per Share (mrq) | 3.81 CNY |
Total Debt (mrq) | 44.04M CNY |
Total Debt/Equity (mrq) | 2.84 CNY |
Current Ratio (mrq) | 2.115 |
Book Value Per Share (mrq) | 9.753 |
Cash Flow Statement
Operating Cash Flow (ttm) | 208.22M CNY |
Levered Free Cash Flow (ttm) | -35480780 CNY |
Profile of Hefei Lifeon Pharmaceutical Co., Ltd.
Country | China |
State | N/A |
City | Hefei |
Address | No 126, KeXue avenue |
ZIP | 230088 |
Phone | 86 551 6535 0389 |
Website | https://www.lifeonapi.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1219 |
Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through pharmaceutical industry, pharmaceutical wholesale and distribution, and pharmaceutical retail business segments. The company offers active pharmaceutical ingredients, which include succimer, urea, paeonol, felodipine, doxazosin mesylate, sodium 2,3-dimercapto-1-propanesulfonate, zofenopril calcium and troxerutin; and medical preparations, such as felodipine, doxazosin mesylate, melbinum glipizide, yiqihewei capsule, kunning granule, armillariella oral solution, paeonol ointment, and urea and vitamin E cream, as well as kecuo yintong and compound golden larch bark gel. In addition, it provides medical intermediate including penicillamine, 3-mercapto-1-propanol, sodium paeonolsilate, and sodium 2,3-dimercapto-1-propanesulfonate; and plant extract products, such as clove and evening primrose oil, herba clinopodii P.E, quercetin, and taxifolin. The company was founded in 2002 and is headquartered in Hefei, China.
Q&A For Hefei Lifeon Pharmaceutical Co., Ltd. Stock
What is a current 003020.SZ stock price?
Hefei Lifeon Pharmaceutical Co., Ltd. 003020.SZ stock price today per share is 20.19 CNY.
How to purchase Hefei Lifeon Pharmaceutical Co., Ltd. stock?
You can buy 003020.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hefei Lifeon Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Hefei Lifeon Pharmaceutical Co., Ltd. is 003020.SZ.
Which industry does the Hefei Lifeon Pharmaceutical Co., Ltd. company belong to?
The Hefei Lifeon Pharmaceutical Co., Ltd. industry is Biotechnology.
How many shares does Hefei Lifeon Pharmaceutical Co., Ltd. have in circulation?
The max supply of Hefei Lifeon Pharmaceutical Co., Ltd. shares is 159.64M.
What is Hefei Lifeon Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hefei Lifeon Pharmaceutical Co., Ltd. PE Ratio is 15.18045100 now.
What was Hefei Lifeon Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hefei Lifeon Pharmaceutical Co., Ltd. EPS is 1.33 CNY over the trailing 12 months.
Which sector does the Hefei Lifeon Pharmaceutical Co., Ltd. company belong to?
The Hefei Lifeon Pharmaceutical Co., Ltd. sector is Healthcare.